Pharmaceuticals, Biotechnology and Life Sciences
PureTech Health’s independent affiliate, resTORbio reported positive topline results from its Phase 2b clinical study with TORC1 inhibitor, that enrolled…
Midatech Pharma said in its trading update it remains on track to meet market expectations for 2018, as it expects…
AstraZeneca will sell the commercial rights to prescription medicine for the treatment of heart failure and hypertension, Atacand and Atacand Plus…
Idorsia operated with US GAAP 155 million CHP ($156M) net loss for the first half of 2018. According to the…
Novartis has signed a renewed memorandum of understanding with the World Health Organization (WHO) to extend its drug donation for Egaten…
Boehringer Ingelheim and Eli Lilly released the positive top-line results from the trial, which evaluated the impact of treatment with…
The National Institute for Health and Care Excellence (NICE) has recommended the use of the EUSA Pharma’s targeted cancer immunotherapy, QARZIBA…
Myovant Sciences has completed screening patients for its LIBERTY 1 study, the first of two Phase 3 replicate studies evaluating…
Alvogen and Prestige BioPharma have entered into a deal for the exclusive partnership and supply for the commercialization of Prestige…
AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the Japanese Ministry of Health, Labour and…